MADEDDU, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 27.975
AS - Asia 17.339
EU - Europa 10.602
SA - Sud America 10.295
AF - Africa 582
Continente sconosciuto - Info sul continente non disponibili 291
OC - Oceania 73
AN - Antartide 1
Totale 67.158
Nazione #
US - Stati Uniti d'America 27.392
BR - Brasile 9.087
SG - Singapore 6.721
CN - Cina 5.792
UA - Ucraina 4.094
DE - Germania 1.518
HK - Hong Kong 1.471
VN - Vietnam 1.359
SE - Svezia 1.209
IT - Italia 1.113
FR - Francia 822
FI - Finlandia 683
AR - Argentina 395
GB - Regno Unito 389
TR - Turchia 308
BD - Bangladesh 221
EC - Ecuador 215
IQ - Iraq 211
IN - India 196
RU - Federazione Russa 195
MX - Messico 180
CA - Canada 177
UZ - Uzbekistan 174
ZA - Sudafrica 163
CO - Colombia 150
VE - Venezuela 143
MA - Marocco 126
PK - Pakistan 116
JP - Giappone 87
ID - Indonesia 81
PY - Paraguay 77
CL - Cile 74
TN - Tunisia 73
UY - Uruguay 64
AU - Australia 61
JO - Giordania 61
KE - Kenya 60
PE - Perù 58
ES - Italia 57
NL - Olanda 54
PL - Polonia 53
BE - Belgio 52
CZ - Repubblica Ceca 51
AZ - Azerbaigian 50
AE - Emirati Arabi Uniti 45
DZ - Algeria 45
KR - Corea 45
NP - Nepal 45
KZ - Kazakistan 44
EU - Europa 42
JM - Giamaica 42
SA - Arabia Saudita 41
EG - Egitto 37
RO - Romania 36
DO - Repubblica Dominicana 34
PH - Filippine 31
HN - Honduras 30
AT - Austria 27
BO - Bolivia 27
AL - Albania 26
IE - Irlanda 26
IL - Israele 26
KG - Kirghizistan 26
PS - Palestinian Territory 25
CR - Costa Rica 24
PA - Panama 24
OM - Oman 23
IR - Iran 22
BY - Bielorussia 20
LT - Lituania 20
GE - Georgia 19
LB - Libano 19
SN - Senegal 19
RS - Serbia 18
GT - Guatemala 17
MK - Macedonia 15
BA - Bosnia-Erzegovina 14
BG - Bulgaria 14
NI - Nicaragua 14
BH - Bahrain 13
GR - Grecia 12
NZ - Nuova Zelanda 12
SV - El Salvador 12
BN - Brunei Darussalam 11
CH - Svizzera 11
MD - Moldavia 11
MY - Malesia 11
NG - Nigeria 10
TT - Trinidad e Tobago 10
AM - Armenia 9
AO - Angola 9
HU - Ungheria 9
QA - Qatar 9
XK - ???statistics.table.value.countryCode.XK??? 9
SY - Repubblica araba siriana 8
ET - Etiopia 7
HR - Croazia 7
DK - Danimarca 6
GA - Gabon 6
PT - Portogallo 6
Totale 66.813
Città #
Dallas 8.012
Singapore 3.136
Chandler 2.880
Jacksonville 2.642
San Jose 1.979
Hong Kong 1.446
Princeton 1.328
Dearborn 1.205
Nanjing 1.136
Ashburn 1.111
Council Bluffs 851
Beijing 845
Columbus 689
São Paulo 636
Wilmington 626
Lauterbourg 573
Ho Chi Minh City 485
Nanchang 415
Shanghai 398
Boardman 342
New York 325
Hanoi 304
Rio de Janeiro 285
Santa Clara 283
Shenyang 276
Belo Horizonte 244
Hebei 242
Sassari 239
Los Angeles 225
Tianjin 222
Changsha 215
Brasília 180
Jiaxing 180
Tashkent 159
Curitiba 128
Porto Alegre 127
San Francisco 117
Hangzhou 107
Guarulhos 103
Ann Arbor 102
Kunming 101
Buffalo 100
Woodbridge 99
Campinas 91
Norwalk 89
Baghdad 88
Goiânia 88
Munich 88
Tokyo 83
Salvador 82
Johannesburg 76
Guayaquil 75
Izmir 68
Manaus 66
Fortaleza 65
Jinan 63
Toronto 62
Frankfurt am Main 61
Dhaka 60
Chicago 59
Quito 59
São José dos Campos 57
Amman 56
Da Nang 56
Ribeirão Preto 56
Sorocaba 56
Montevideo 55
Zhengzhou 55
Haiphong 52
Recife 52
Nairobi 51
Brooklyn 50
Brussels 50
Caxias do Sul 50
Guangzhou 50
São Bernardo do Campo 50
Istanbul 49
Milan 48
Juiz de Fora 47
Baku 46
Bauru 46
Campo Grande 46
Rome 46
Santo André 46
Betim 45
Bogotá 44
Contagem 44
Denver 44
Orem 44
Osasco 44
Uberlândia 44
Chennai 43
Seoul 43
Joinville 41
London 41
Montreal 41
Ningbo 41
Volta Redonda 41
Brno 40
Ipatinga 40
Totale 38.271
Nome #
Terapia con CBZ e diaschisi cerebellare crociata 354
123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders 286
Accuracy of sentinel node biopsy in predicting nodal status in patients with breast carcinoma 275
123I-FP-CIT brain SPECT: tracer uptake values of right putamen are the most discriminant to diagnose Parkinson’s disease. 274
123I-FP-CIT SPECT: a new diagnostic method for Parkinson Disease 273
111In-pentetreotide SPECT and SPECT/CT vs conventional imaging procedures (CIP) in non-functioning gastroenteropancreatic neuroendocrine tumor (GEP) patient management. 253
111InPentetreotide SPECT and SPECT/CT in non functioning gastroenteropancreatic neuroendocrine tumors (GEP). 251
(111) In-pentetreotide SPECT/CT in gastroenteropancreatic (GEP) 246
111In-Pentetreotide SPECT/CT in neuroendocrine gastroenteropancreatic (GEP) tumors 240
(111) In-pentetreotide SPECT/CT in pulmonary carcinoid (PC) 240
123I Ioflupane SPECT in the differential diagnosis of Lewy bodies Dementia 239
111In pentetreotide SPECT/CT in neuroendocrine tumor (NETs) diagnostic management. 239
123I FP-CIT SPECT and 99mTc HM-PAO SPECT combined use in patients with associated movement and cognitive disorders 236
123I FP-CIT SPECT in early Parkinson’s disease 233
123I-FP-CIT brain SPECT data by means of a support vector machine classifier (SVM) to diagnose Parkinson’s disease. 230
123I-FP-CIT SPECT in the diagnosis of Parkinson’s disease in early stage. 225
123I-FP-CIT SPECT usefulness in early stage Parkinson’s Disease 220
99mTc-tetrofosmin SPECT in solitary pulmonary nodule evaluation 219
99mTc-Tetrofosmin Pinhole-SPECT (P-SPECT) and Radioguided sentinel node (SN) biopsy and in breast cancer axillary lymph node staging 212
123I-MetalodoBenzylGuanidine (123I-MIBG) cardiac scintigraphy in the differential diagnosis of neurodegenerative movements disorders 212
99mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis 201
111In-pentetreotide SPECT/CT for functional anatomical mapping in patients with pulmonary carcinoid. 196
(99mTC)sestamibi and (99mTc)tetrofosmin in oncology: SPET and fusion imaging in lung cancer, malignant lymphomas and brain tumors 192
99mTc-tetrofosmin SPECT: a useful diagnostic tool in breast cancer (BC) detection 187
12. Prolactin (PRL) response to Thyrotropin Releasing Hormone (TRH) in patients with subacute thyroiditis in the early stage. 187
131I-SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinomas (DTC) in long-term follow-up 187
99mTc HM-PAO Brain Spect Qualitative and Quantitative Analyses (QLA/QNA) In Fibromyalgia Syndrome (FMS) Treated With Hyperbaric Oxigen Therapy (HOT) 179
A FOLLOW-UP-STUDY OF SURGICALLY TREATED AUTONOMOUS THYROID-NODULES 179
123I-Ioflupane SPECT reduced parental glutathione (GSH) therapy evaluation in Parkinson’s disease (PD) 178
The value of preoperative molecular breast imaging for the size assessment of invasive carcinoma and ductal carcinoma in situ 178
Beta2-microglobulin and Neopterin: predictive markers of AIDS in HIV infection 175
Breast scintigraphy with breast-specific γ-camera (BSGC) in the detection of ductal carcinoma in situ (DCIS): a correlation with mammography and histologic subtype. 169
The role of molecular breast imaging in predicting complete tumor response to treatment and residual tumor extent following neoadjuvant therapy 168
99mTc-tetrofosmin molecular breast imaging (MBI) with high resolution dedicated breast camera (DBC) and breast dynamic magnetic resonance imaging (MRI) in the preoperative staging of breast cancer: a comparative study. 167
99mTc-Tetrofosmin scan in non small cell lung cancer (NSCLC) 166
18F-FDG PET/CT Usefulness In Primary Progressive Aphasia (PPA) Variants And In Fronto-Temporal Dementia (FTD) Or Alzheimer’s Disease (AD) Development. 163
The value of semiquantitative FDG-PET parameters in the diagnosis of solitary pulmonary nodules with pre-test intermediate likelihood of malignancy: a single-centre study 157
Role of an artificial neural network classifier, a classification tree (ClT), to diagnose Parkinson’s disease in early phase by using 123I-FP-CIT brain SPECT data. 156
99mTc-Tetrofosmin axillary planar, SPECT and Pinhole SPECT (P-SPECT) in breast cancer (BC) non palpable lymph node metastases detection 156
99mTc-tetrofosmin SPECT/CT in solitary pulmonary nodule (SPN) evaluation. 156
Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy 155
123I-MIBG Cardiac Scintigraphy and123I-IOFLUPANE SPECT Combined Use In Uncertain Parkinsonian Syndromes 155
The usefulness of SPECT/CT and neck pinhole SPECT (P-SPECT) as complementary tools to planar parathyroid scintigraphy in hyperparathyroidism (HPT). 155
18F-FDG PET/CT in patients with autoimmune encephalitis in the early stage. 154
Combined 123I-Iofuplane SPECT and 123I-MIBG cardiac scintigraphy use in Parkinson disease(PD) and vascular Parkinsonism(VP) differential diagnosis. 154
Neck iodine fixing foci in differentiated thyroid carcinoma (DTC) follow-up patients: a 131 I-SPECT/CT study. 153
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study. 150
99mTc-tetrofosmin SPECT in solitary pulmonary nodule evaluation 149
Somatostatin receptor scintigraphy with 111In-pentetreotide in non-functioning gastroenteropancreatic neuroendocrine tumors 148
The role of 99mTc-tetrofosmin Pinhole-SPECT in breast cancer axillary lymph node staging 148
The diagnostic usefulness of131i-spect/ct at both radioiodine ablation and during long-term follow-up in patients thyroidectomized for differentiated thyroid carcinoma: Analysis of tissue risk factors ascertained at surgery and correlated with metastasis appearance 147
Beta-endorphin in experimental canine spinal ischemia. 145
Body composition change in hiv-infected patients treated with HAART: a longitudinal DEXA study. 144
123I-MIBG cardiac scintigraphy quantitative analysis in Parkinson’s disease (PD) and Parkinsonisms (P) differential diagnosis: a classification tree (CIT) classifier additional contribute. 143
Qualitative (Q) and semiquantitative (SQ) brain 18FFDG PET analyses in primary progressive aphasia (PPA) variants 143
The classification tree (CIT) classifier applied by 123I-MIBG cardiac scintigraphy in differentiating Parkinson’s disease (PD) from Parkinsonism (P). 142
131I SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC). 141
123I-MIBG cardiac scintigraphy in discriminating Parkinson’s disease (PD) from vascular Parkinsonism (VP ) using classification tree( CIT ) classifier together with conventional quantitative analysis. 141
18F-FDG PET/CT in intracranial leptomeningeal carcinomatosis 141
Neck lymph node metastases in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a diagnostic 131I-SPECT/CT study 141
18F-FDG Brain PET/CT Metabolic Imaging in Patients with Suspected Autoimmune Encephalitis (AE) in the Early Stage: Can the Procedure Play a Complementary Diagnostic Role? 141
99mTc-tetrofosmin SPECT/CT in lung lesion detection. 140
Brain 18F-FDG PET qualitative and quantitative analyses in Atypical Parkinsonian Syndromes (APS) with Cognitive Clinical Symptoms (CCS) 140
Body composition evaluation by DEXA in the follow up of HIV patients treted with HAART. 140
Alteration in thyrotropin (TSH), Prolactin (PRL) and Growth Hormone (GH) secretions in chronic alcoholism and in liver cirrhosis. 139
Tc 99m-Tetrofosmin scan in lung and breast cancer detection 139
131I-SPECT/CT usefulness in the follow up of patients thyroidectomized for thyroid papillary microcarcinoma ( PTMC). 139
Beta-endorphin in experimental spinal traumas 138
Intracranial Leptomeningeal Carcinomatosis: A Diagnostic Study with18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography 137
Alterazioni degli indici di funzionalità tiroidea nelle epatopatie croniche. 137
Behavioral disturbances associated with hyperostosis frontalis interna: a neuroimaging study 137
Plasma levels of leptin in heavy obese subjects 135
Beta-endorphin in experimental spinal traumas 135
Caratterizzazione clinica del miocardio ibernato identificato mediante scintigrafia miocardica con Tallio-201. 135
Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a 131I-SPECT/CT study. 133
Alpha-fetoprotein and Hepatitis B Virus infection in chronic liver disease 132
Tc-99m Tetrofosmin (T) scintigraphy in patients with abdominal cancer 132
Breast scintigraphy with a breast specific gamma camera (BSGC) and dynamic breast magnetic resonance imaging (MRI) in the detection of primary breast cancer (BC): A comparative study 132
Free/Total PSA ratio (F/T) and total (T) PSA combined use in monitoring finasteride (F) treated benign prostatic hyperplasia (BPH) 132
Beta-endorphin and cortisol levels in plasma and cerebral fluid (CSP) in experimental spinal cord injury. 132
Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma: A Follow-Up Study in Patients with Absence of Aggressive Risk Factors at the Surgery of the Primary Tumor 130
131I-SPECT/CT in differentiating neck iodine fixing foci in patients with differentiated thyroid carcinoma (DTC). 130
The usefulness of 99mTc-tetrofosmin SPECT in the detection of intrathoracic malignant lesions 129
Breast-specific imaging (BSGI) in predicting tumor response to treatment and in assessing residual tumor size following neoadjuvant therapy in locally advanced primary breast cancer. 129
Beta-Endorphin and cortisol in experimental spinal trauma 128
The use of neck pinhole SPECT in hyperparathyroidism and differentiated thyroid carcinoma 128
99mTc-tetrofosmin molecular breast imaging (MBI) with high resolution dedicated breast camera (DBC) and breast dynamic magnetic resonance imaging (MRI) in the preoperative locl staging of primary breast cancer. 128
99mTc-tetrofosmin planar scintimammography and SPECT in monitoring the response to neoadjuvant hormone or chemotherapy in locally advanced primary breast cancer (LAPBC) 127
Somatostatin receptor scintigraphy (SRS) in the detection of liver metastases from gastroenteropancreatic neuroendocrine tumours (GEP) 127
Beta-Endorphin in Experimental Spinal traumas. 127
A longitudinal study on bone metabolism in HIV patients treated with HAART. 126
Breast scintigraphy with brest specific gammacamera (BSGC) and dynamic contrast enhanced magnetic resonance imaging (DCE-MRI ) in local staging and tumor size assessment of primary breast cancer. 126
Bone Alkaline Phosphatase (BAP) related to Prostate Specific Antigen (PSA) in bone metastasis prostate cancer (PC) patients 125
Alzheimer disease (AD) and Lewy bodies dementia (LBD) differential diagnosis: a 123Ioflupane SPECT study. 125
Random Forest Classifier contribution in the differential diagnosis of movement disorders studied by 123 I-MIBG cardiac scintigraphy. 125
Qualitative and Quantitative Analyses of Brain 18Fluoro-Deoxy-Glucose Positron Emission Tomography in Primary Progressive Aphasia 125
Primary Progressive Aphasia (PPA) variants: a diagnostic brain 18F-FDG PET/CT study 125
131I-SPECT/CT in the diagnosis and characterization of metastatic lesions in patients with differentiated thyroid carcinoma (DTC) in chronic follow-up 125
SPECT/CT with a hybrid imaging system in the study of lower gastrointestinal bleeding with technetium-99m red blood cells 124
The usefulness of 99mTc-tetrofosmin SPECT in monitoring the response to chemotherapy in lung cancer patients 124
Totale 16.661
Categoria #
all - tutte 278.168
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 278.168


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.226 0 14 16 8 12 13 76 212 219 140 287 1.229
2022/20235.792 708 188 46 997 618 983 16 746 1.016 41 306 127
2023/20241.734 310 143 66 75 394 91 20 40 8 11 153 423
2024/202516.766 105 122 944 184 565 456 1.129 3.853 6.501 1.980 525 402
2025/202622.541 683 6.118 3.064 3.677 1.565 1.049 3.010 841 1.012 794 459 269
2026/20272.173 570 1.603 0 0 0 0 0 0 0 0 0 0
Totale 67.158